Ultragyors hatású humán inzulinanalógok: Új lehetoség a cukorbetegség kezelésében

Translated title of the contribution: Rapid-acting human insulin analogues: New possibilities in the therapy of diabetes mellitus

Research output: Contribution to journalArticle

Abstract

Modifications of the insulin molecule at the end of the B chain resulted in the development of some new, more physiological meal-related insulins, the rapid acting human insulin analogues. This survey summarises the characteristics (structure, absorption, immunogenicity, efficacy and safety) and the conditions of clinical application of the rapid-acting insulin analogues available at the moment in Hungary. Furthermore, authors evaluate the effect of application of rapid-acting insulin analogues on the quality of life and glycaemic control of the patients. The collaboration between the well-prepared health-care team and the well-educated and cooperative diabetic patient using rapid-acting insulin analogue could lead to a level of freedom of lifestyle that approximates that of healthy people.

Original languageHungarian
Pages (from-to)223-228
Number of pages6
JournalLege Artis Medicinae
Volume12
Issue number4
Publication statusPublished - 2002

Fingerprint

Short-Acting Insulin
Diabetes Mellitus
Insulin
Patient Care Team
Hungary
Therapeutics
Meals
Quality of Life
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ultragyors hatású humán inzulinanalógok : Új lehetoség a cukorbetegség kezelésében. / Kerényi, Z.; Tamás, G.

In: Lege Artis Medicinae, Vol. 12, No. 4, 2002, p. 223-228.

Research output: Contribution to journalArticle

@article{8c406288b788428dbff1044b45cf36e4,
title = "Ultragyors hat{\'a}s{\'u} hum{\'a}n inzulinanal{\'o}gok: {\'U}j lehetos{\'e}g a cukorbetegs{\'e}g kezel{\'e}s{\'e}ben",
abstract = "Modifications of the insulin molecule at the end of the B chain resulted in the development of some new, more physiological meal-related insulins, the rapid acting human insulin analogues. This survey summarises the characteristics (structure, absorption, immunogenicity, efficacy and safety) and the conditions of clinical application of the rapid-acting insulin analogues available at the moment in Hungary. Furthermore, authors evaluate the effect of application of rapid-acting insulin analogues on the quality of life and glycaemic control of the patients. The collaboration between the well-prepared health-care team and the well-educated and cooperative diabetic patient using rapid-acting insulin analogue could lead to a level of freedom of lifestyle that approximates that of healthy people.",
keywords = "Clinical application, Glycaemic control, Insulin treatment, Rapid acting insulin analogues",
author = "Z. Ker{\'e}nyi and G. Tam{\'a}s",
year = "2002",
language = "Hungarian",
volume = "12",
pages = "223--228",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "4",

}

TY - JOUR

T1 - Ultragyors hatású humán inzulinanalógok

T2 - Új lehetoség a cukorbetegség kezelésében

AU - Kerényi, Z.

AU - Tamás, G.

PY - 2002

Y1 - 2002

N2 - Modifications of the insulin molecule at the end of the B chain resulted in the development of some new, more physiological meal-related insulins, the rapid acting human insulin analogues. This survey summarises the characteristics (structure, absorption, immunogenicity, efficacy and safety) and the conditions of clinical application of the rapid-acting insulin analogues available at the moment in Hungary. Furthermore, authors evaluate the effect of application of rapid-acting insulin analogues on the quality of life and glycaemic control of the patients. The collaboration between the well-prepared health-care team and the well-educated and cooperative diabetic patient using rapid-acting insulin analogue could lead to a level of freedom of lifestyle that approximates that of healthy people.

AB - Modifications of the insulin molecule at the end of the B chain resulted in the development of some new, more physiological meal-related insulins, the rapid acting human insulin analogues. This survey summarises the characteristics (structure, absorption, immunogenicity, efficacy and safety) and the conditions of clinical application of the rapid-acting insulin analogues available at the moment in Hungary. Furthermore, authors evaluate the effect of application of rapid-acting insulin analogues on the quality of life and glycaemic control of the patients. The collaboration between the well-prepared health-care team and the well-educated and cooperative diabetic patient using rapid-acting insulin analogue could lead to a level of freedom of lifestyle that approximates that of healthy people.

KW - Clinical application

KW - Glycaemic control

KW - Insulin treatment

KW - Rapid acting insulin analogues

UR - http://www.scopus.com/inward/record.url?scp=0036314572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036314572&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036314572

VL - 12

SP - 223

EP - 228

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 4

ER -